
The current AEZS market cap is 10.26M. The company's latest EPS is USD -8.5382 and P/E is -0.55.
Quarter End | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3k | 4k | 2.34M | 1.87M | 1.5M |
Operating Income | -4.55M | -6.11M | -3.76M | -6.29M | -3.62M |
Net Income | -4.15M | -5.75M | -1.42M | -5.76M | -3.66M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.87M | 5.26M | 5.64M | 4.5M | 9.59M |
Operating Income | -5.96M | -5.33M | -20.99M | -18.01M | -18.28M |
Net Income | -5.12M | -8.37M | -22.73M | -16.55M | -15.31M |
Quarter End | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 42.49M | 31.79M | 50.05M | 43.77M | 31.14M |
Total Liabilities | 16.21M | 18.82M | 23.82M | 23.76M | 21M |
Total Equity | 26.28M | 12.97M | 26.23M | 20.01M | 10.14M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 37.28M | 80.1M | 56.03M | 37.02M | 35.07M |
Total Liabilities | 24.07M | 27.12M | 20.25M | 18.82M | 21.91M |
Total Equity | 13.21M | 52.99M | 35.78M | 18.2M | 13.16M |
Quarter End | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.38M | -4.29M | -1.39M | -7.78M | -1.88M |
Investing | -10k | -5k | 25.88M | 83k | -615k |
Financing | -33k | -42k | -126k | -188k | -200k |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.13M | -8.58M | -13.68M | -17.12M | -14.57M |
Investing | 56k | -658k | -12k | 528k | 25.08M |
Financing | 20.47M | 51.04M | -118k | -151k | -588k |
Market Cap | 10.26M |
Price to Earnings Ratio | -0.55 |
Price to Sales Ratio | 0.87 |
Price to Cash Ratio | 0.51 |
Price to Book Ratio | 0.64 |
Dividend Yield | - |
Shares Outstanding | 1.79M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.67 (10.49%) |
Company Name | Aeterna Zentaris Inc |
Address |
aeterna zentaris inc toronto, ontario M5K 1E7 |
Website | https://www.zentaris.com/ |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.